Walleye Capital LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Walleye Capital LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $874,000 - $960,982	1,900 Added 12.03%	17,700 $8.23 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $5.97 Million - $7.38 Million	-15,200 Reduced 49.03%	15,800 $7.41 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $11.1 Million - $12.2 Million	27,300 Added 737.84%	31,000 $13 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $1.3 Million - $1.56 Million	-3,800 Reduced 50.67%	3,700 $1.51 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $282,978 - $316,719	-900 Reduced 10.71%	7,500 $2.64 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $594,783 - $678,510	2,100 Added 33.33%	8,400 $2.65 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.4 Million - $1.58 Million	4,900 Added 350.0%	6,300 $1.82 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $383,362 - $427,741	1,400 New	1,400 $405,000
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $9.59 Million - $12.9 Million	-57,500 Reduced 64.9%	31,100 $6.81 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $10.2 Million - $11.4 Million	61,200 Added 223.36%	88,600 $15 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $2.81 Million - $3.26 Million	17,100 Added 166.02%	27,400 $5.03 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $1.69 Million - $2.01 Million	10,300 New	10,300 $1.9 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.